<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Price-Fixing Charges on FinanClub</title>
    <link>https://finan.club/tags/price-fixing-charges/</link>
    <description>Recent content in Price-Fixing Charges on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 02 Sep 2023 03:09:16 +0000</lastBuildDate><atom:link href="https://finan.club/tags/price-fixing-charges/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>TEVA</title>
      <link>https://finan.club/us/teva/</link>
      <pubDate>Sat, 02 Sep 2023 03:09:16 +0000</pubDate>
      
      <guid>https://finan.club/us/teva/</guid>
      <description>score:203
Chances: Teva stock pops on Q2 results, CEO sees &amp;lsquo;significant&amp;rsquo; potential for trio of branded drugs Teva’s 3rd interim analysis of PEARL real-world study on AJOVY® (fremanezumab) reveals sustained long-term effectiveness in reducing frequency, duration, and severity of attacks in patients with chronic and episodic migraine Teva Reaches Agreement With Kentucky to Settle the State’s Price Fixing Claims Risks: Teva to Pay $225 Million to Settle Price-Fixing Charges (Revised) Teva Agrees to Pay $225 Million to Settle Price-Fixing Charges Teva considers sale of its active ingredients unit: Bloomberg Score:203 investment score = chances characters count - risks characters count</description>
    </item>
    
  </channel>
</rss>
